Clinical Trial Update: Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 randomized pilot study evaluating apixaban in patients with atrial fibrillation undergoing cardiac implantable electronic device procedures has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Mayo Clinic | Conditions: Atrial Fibrillation | Phase 2 | Status: WITHDRAWN